APA

Kim J. H., Park B., Gupta S. C., Kannappan R., Sung B. & Aggarwal B. B. (20120914). Zyflamend sensitizes tumor cells to TRAIL-induced apoptosis through up-regulation of death receptors and down-regulation of survival proteins: role of ROS-dependent CCAAT/enhancer-binding protein-homologous protein pathway. : Antioxidants & redox signaling.

Chicago

Kim Ji Hye, Park Byoungduck, Gupta Subash C, Kannappan Ramaswamy, Sung Bokyung and Aggarwal Bharat B. 20120914. Zyflamend sensitizes tumor cells to TRAIL-induced apoptosis through up-regulation of death receptors and down-regulation of survival proteins: role of ROS-dependent CCAAT/enhancer-binding protein-homologous protein pathway. : Antioxidants & redox signaling.

Harvard

Kim J. H., Park B., Gupta S. C., Kannappan R., Sung B. and Aggarwal B. B. (20120914). Zyflamend sensitizes tumor cells to TRAIL-induced apoptosis through up-regulation of death receptors and down-regulation of survival proteins: role of ROS-dependent CCAAT/enhancer-binding protein-homologous protein pathway. : Antioxidants & redox signaling.

MLA

Kim Ji Hye, Park Byoungduck, Gupta Subash C, Kannappan Ramaswamy, Sung Bokyung and Aggarwal Bharat B. Zyflamend sensitizes tumor cells to TRAIL-induced apoptosis through up-regulation of death receptors and down-regulation of survival proteins: role of ROS-dependent CCAAT/enhancer-binding protein-homologous protein pathway. : Antioxidants & redox signaling. 20120914.